Evaluation of the Role of Poisoning Severity Score, Serum Procalcitonin and C-reactive Protein in Acute Hydrocarbon Intoxicated Cases Admitted to the Poison Control Center Ain Shams University Hospitals

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06151301
Collaborator
(none)
60
1
12
5

Study Details

Study Description

Brief Summary

Hydrocarbons are a primary energy source in modern society. They are present in many common household and occupational products, including motor fuels, paint thinners, cleaning agents, lotions, and industrial solvents. Unfortunately, these products are also used as agents of abuse and typically inhaled .

They are derived mainly from petroleum (kerosene, gas, naphtha) or wood (turpentine, pine oil). They can be found in liquid, gas, or solid form depending on their properties. All hydrocarbons can be toxic, but aromatic (ring-shaped) and halogenated hydrocarbons typically have more severe toxicity .

Toxicity occurs in various ways including through inhalation, ingestion, aspiration, and dermal exposure. Frequently, these exposures occur during attempted recreational use of the substances and sometimes for self-injurious behavior

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: serum procalcitonin
  • Diagnostic Test: C-reactive protein

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Evaluation of the Role of Poisoning Severity Score, Serum Procalcitonin and C-reactive Protein in Acute Hydrocarbon Intoxicated Cases Admitted to the Poison Control Center Ain Shams University Hospitals
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
control group

20 subjects of apparently healthy persons for estimating the standard levels of the tested biomarkers.

Diagnostic Test: serum procalcitonin
predicting the severity of intoxication

Diagnostic Test: C-reactive protein
predicting the severity of intoxication

case group

60 patients divided into mild, moderate and severe toxicity according to the poisoning severity score.

Diagnostic Test: serum procalcitonin
predicting the severity of intoxication

Diagnostic Test: C-reactive protein
predicting the severity of intoxication

Outcome Measures

Primary Outcome Measures

  1. Serum procalcitonin level [1 year]

    measuring the level of serum procalcitonin (reference range 0-0.05µg/L)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients of both sexes admitted to the Poison control center, Ain Shams university hospitals with acute hydrocarbon toxicity during the duration from December 2023 till December 2024 with a maximum number of 60 cases within 24 hours of intoxication.

Exclusion Criteria:
Patients with these criteria will be excluded:
  • Cases > 24 hours of intoxication.

  • Cases with occupational exposure to hydrocarbons.

  • Pregnant females.

  • Any cases received any treatment before arrival to the PCC.

  • Cases suffering from cardiac, respiratory, renal, hepatic or haematological disorders.

  • Cases presenting with fever.

  • Cases with other causes that can increase levels of CRP & pro-calcitonin as bacterial infection, recent major trauma, major burn ,septic shock and medullary thyroid cancer.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ain Shams university Hospital Cairo Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mera Gergis khalil, assistant lecteurer Forensic medicine and Toxicology department sohag univerisity hospital, Sohag University
ClinicalTrials.gov Identifier:
NCT06151301
Other Study ID Numbers:
  • Soh-Med-23-11-01MD
First Posted:
Nov 30, 2023
Last Update Posted:
Nov 30, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2023